Episurf Medical AB (Episurf Medical), formerly Diamorph Medtech AB is a medical technology company that provides patient-specific treatments for painful joint injuries. It offers diagnosis and design of implants and surgical instruments. Its product portfolio includes Episealer Femoral Twin, Episealer Trochlea Solo, Episealer Trochlea Twin, Epiguide and toolkit; and MRI protocol. Episurf Medical’s Episealer Condyle Solo is a patient-specific resurfacing implant intended for the knee condyle for the treatment of localized cartilage and underlying bone defects. The company also offers patient-specific joint resurfacing implants. Its products are used in the repair of localized cartilage and underlying bone defects in the knees, trochlea area in the knee, and other condyles and trochlea areas. Episurf Medical is headquartered in Stockholm, Sweden.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Episurf Medical AB
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Episurf Medical AB Company Overview
- Episurf Medical AB Company Snapshot
- Episurf Medical AB Pipeline Products and Ongoing Clinical Trials Overview
- Episurf Medical AB - Pipeline Analysis Overview
- Episurf Medical AB - Key Facts
- Episurf Medical AB - Major Products and Services
- Episurf Medical AB Pipeline Products by Development Stage
- Episurf Medical AB Ongoing Clinical Trials by Trial Status
- Episurf Medical AB Pipeline Products Overview
- Episealer Condyle Solo
- Episealer Condyle Solo Product Overview
- Episealer Condyle Solo Clinical Trial
- Episealer Femoral Twin
- Episealer Femoral Twin Product Overview
- Episealer Femoral Twin Clinical Trial
- Episealer MTP System
- Episealer MTP System Product Overview
- Episealer Talus Implant
- Episealer Talus Implant Product Overview
- Episealer Talus Implant Clinical Trial
- Episealer Trochlea Solo
- Episealer Trochlea Solo Product Overview
- Episealer Trochlea Solo Clinical Trial
- Episurf Medical AB - Key Competitors
- Episurf Medical AB - Key Employees
- Episurf Medical AB - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Episurf Medical AB, Recent Developments
- Mar 07, 2024: Episurf Medical AB's 2023 Annual Report is Available
- Jan 16, 2024: Results from up to 10 years follow-up of Episealer patients accepted for presentation at international orthopaedic congress
- Nov 28, 2023: New Patent Approvals for Episurf Medical
- Oct 27, 2023: Episurf Medical Interim Report 1 January - 30 September 2023
- Sep 25, 2023: Episealer Presentations at Several Clinical Congresses
- Sep 14, 2023: Scientific Article on Episealer Talus Surgical Technique Published in Foot & Ankle Clinics
- Sep 13, 2023: Prospective Episealer Talus clinical study fully recruited
- Aug 31, 2023: Episurf Medical: Approaching 510(k) Submission for Big Toe Implant
- Aug 23, 2023: Episurf Medical: First Commercial Case in the US Scheduled
- Jul 31, 2023: Results From the Use of Episealer Accepted for Publication in Scientific Journal
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Episurf Medical AB Pipeline Products and Ongoing Clinical Trials Overview
- Episurf Medical AB Pipeline Products by Equipment Type
- Episurf Medical AB Pipeline Products by Indication
- Episurf Medical AB Ongoing Clinical Trials by Trial Status
- Episurf Medical AB, Key Facts
- Episurf Medical AB, Major Products and Services
- Episurf Medical AB Number of Pipeline Products by Development Stage
- Episurf Medical AB Pipeline Products Summary by Development Stage
- Episurf Medical AB Ongoing Clinical Trials by Trial Status
- Episurf Medical AB Ongoing Clinical Trials Summary
- Episealer Condyle Solo - Product Status
- Episealer Condyle Solo - Product Description
- Episealer Condyle Solo - A Prospective, Randomized, Controlled, Multi-center Study to Evaluate the Safety and Effectiveness of the Episealer Knee System Compared to Microfracture for the Treatment of Focal Femoral Knee Chondral or Osteochondral Lesions
- Episealer Condyle Solo - Efficacy of Focal Individualised Mini-metal Implant in Treatment of Focal Cartilage Lesions in the Knee
- Episealer Condyle Solo - Prospective Interventional Clinical Trial of an MRI Based Patient Specific Focal Knee Resurfacing Implant
- Episealer Condyle Solo - X-ray Fluoroscopic Analysis of Knee Joint Kinematic in Open and Closed Chain Activities in Patients with Episealer Knee Implants
- Episealer Femoral Twin - Product Status
- Episealer Femoral Twin - Product Description
- Episealer Femoral Twin - A Prospective, Randomized, Controlled, Multi-center Study to Evaluate the Safety and Effectiveness of the Episealer Knee System Compared to Microfracture for the Treatment of Focal Femoral Knee Chondral or Osteochondral Lesions
- Episealer Femoral Twin - Efficacy of Focal Individualised Mini-metal Implant in Treatment of Focal Cartilage Lesions in the Knee
- Episealer Femoral Twin - X-ray Fluoroscopic Analysis of Knee Joint Kinematic in Open and Closed Chain Activities in Patients with Episealer Knee Implants
- Episealer MTP System - Product Status
- Episealer MTP System - Product Description
- Episealer Talus Implant - Product Status
- Episealer Talus Implant - Product Description
- Episealer Talus Implant - A European Multi-center Study of Episealer Talus Implant for the Treatment of Osteochondral Ankle Lesions
- Episealer Talus Implant - A Prospective Study of Episealer Talus Implant in the Treatment of Patients with Osteochondral Defects
- Episealer Talus Implant - A Retrospective, Observational, Post-market Clinical Investigation on the Outcome of Episealer Talus Post-operation for Treatment of Focal Osteochondral Defects
- Episealer Trochlea Solo - Product Status
- Episealer Trochlea Solo - Product Description
- Episealer Trochlea Solo - A Prospective, Randomized, Controlled, Multi-center Study to Evaluate the Safety and Effectiveness of the Episealer Knee System Compared to Microfracture for the Treatment of Focal Femoral Knee Chondral or Osteochondral Lesions
- Episealer Trochlea Solo - An Investigator-initiated European Multi-center Study of Episealer in Knee Patients
- Episealer Trochlea Solo - Efficacy of Focal Individualised Mini-metal Implant in Treatment of Focal Cartilage Lesions in the Knee
- Episealer Trochlea Solo - Long-term Prospective Interventional Clinical Trial of an MRI Based Patient Specific Focal Knee Resurfacing Implant
- Episealer Trochlea Solo - X-ray Fluoroscopic Analysis of Knee Joint Kinematic in Open and Closed Chain Activities in Patients with Episealer Knee Implants
- Episurf Medical AB, Key Employees
- Episurf Medical AB, Subsidiaries
- Glossary
- Episurf Medical AB Pipeline Products by Equipment Type
- Episurf Medical AB Pipeline Products by Development Stage
- Episurf Medical AB Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Tigran Technologies AB
- Dignitana AB
- C-Rad AB
- Camp Scandinavia AB
- Boule Diagnostics AB
- Anatomica AB
